ArticleThe Neurohospitalist2012
Avoidable 30-day readmissions among patients with stroke and other cerebrovascular disease.
Article in The Neurohospitalist, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Factors associated with post-stroke readmission: a systematic review and meta analysis.Scientific reports · 2025Pooled it
- Towards a patient journey perspective on causes of unplanned readmissions using a classification framework: results of a systematic review with narrative synthesis.BMC medical research methodology · 2019Pooled it
- Prevalence, causes and risk factors of hospital readmissions after acute stroke and transient ischemic attack: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2016Pooled it
- Trial
- Readmission Rates Among Acute Reperfusion Treatment Modalities for Patients With Ischemic Stroke.The Neurohospitalist · 2024Article
- Rates and reasons for hospital readmission after acute ischemic stroke in a US population-based cohort.PloS one · 2023Article
- Implementing a Neurohospitalist Program Improves Stroke Care Metrics and Patient Satisfaction Scores.The Neurohospitalist · 2022Article
- High Risk Features Contributing to 30-Day Readmission After Acute Ischemic Stroke: A Single Center Retrospective Case-Control Study.The Neurohospitalist · 2022Article
- Pre-stroke disability and stroke severity as predictors of discharge destination from an acute stroke ward.Clinical medicine (London, England) · 2021Article
- Patient Characteristics Associated With Readmission to 3 Neurology Services at an Urban Academic Center.The Neurohospitalist · 2021Article
- Relationship between early follow-up and readmission within 30 and 90 days after ischemic stroke.Neurology · 2020Article
- Patient Factors Associated With Attendance at a Comprehensive Postacute Stroke Visit: Insight From the Vanguard Site.Archives of rehabilitation research and clinical translation · 2020Article
- Comparisons of readmissions and mortality based on post-discharge ambulatory follow-up services received by stroke patients discharged home: a register-based study.BMC health services research · 2019Article
- Association between medication-related adverse events and non-elective readmission in acute ischemic stroke.BMC neurology · 2018Article
- Article
- Impact of Neurological Follow-Up on Early Hospital Readmission Rates for Acute Ischemic Stroke.The Neurohospitalist · 2017Article
- Many Neurology Readmissions Are Nonpreventable.The Neurohospitalist · 2017Article
- Sequence Analysis of Long-Term Readmissions among High-Impact Users of Cerebrovascular Patients.Stroke research and treatment · 2017Article
- Integrating the Principles of Evidence Based Medicine and Evidence Based Public Health: Impact on the Quality of Patient Care and Hospital Readmission Rates in Jordan.International journal of integrated care · 2016Article
- Transitional care strategies from hospital to home: a review for the neurohospitalist.The Neurohospitalist · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are limited data on factors associated with 30-day readmissions and the frequency of avoidable readmissions among patients with stroke and other cerebrovascular disease.
methodsUniversity HealthSystem Consortium (UHC) database records were used to identify patients discharged with a diagnosis of stroke or other cerebrovascular disease at a university hospital from January 1, 2007 to December 31, 2009 and readmitted within 30 days to the index hospital. Logistic regression models were used to identify patient and clinical characteristics associated with 30-day readmission. Two neurologists performed chart reviews on readmissions to identify avoidable cases.
resultsOf 2706 patients discharged during the study period, 174 patients had 178 readmissions (6.4%) within 30 days. The only factor associated with 30-day readmission was the index length of stay >10 days (vs <5 days; odds ratio [OR] 2.3, 95% CI [1.4, 3.7]). Of 174 patients readmitted within 30 days (median time to readmission 10 days), 92 (53%) were considered avoidable readmissions including 38 (41%) readmitted for elective procedures within 30 days of discharge, 27 (29%) readmitted after inadequate outpatient care coordination, 15 (16%) readmitted after incomplete initial evaluations, 8 (9%) readmitted due to delayed palliative care consultation, and 4 (4%) readmitted after being discharged with inadequate discharge instructions. Only 5% of the readmitted patients had outpatient follow-up recommended within 1 week.
conclusionsMore than half of the 30-day readmissions were considered avoidable. Coordinated timing of elective procedures and earlier outpatient follow-up may prevent the majority of avoidable readmissions among patients with stroke and other cerebrovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.